Cargando…

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study

BACKGROUND: The role of the complement system in the pathogenesis of systemic sclerosis (SSc) is controversial. This study investigated the role of the lectin pathway of complement as a mediator of ischemia/reperfusion injury in SSc. METHODS: This is a prospective observational cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osthoff, Michael, Jaeger, Veronika K., Heijnen, Ingmar A. F. M., Trendelenburg, Marten, Jordan, Suzana, Distler, Oliver, Walker, Ulrich A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423822/ https://www.ncbi.nlm.nih.gov/pubmed/30885245 http://dx.doi.org/10.1186/s13075-019-1859-1

Ejemplares similares

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor
por: Panagiotou, Anneza, et al.
Publicado: (2018)

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study
por: Charitos, Panteleimon, et al.
Publicado: (2021)

Impact of Mannose-Binding Lectin Deficiency on Radiocontrast-Induced Renal Dysfunction
por: Osthoff, Michael, et al.
Publicado: (2013)

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases
por: Vogt, Severin, et al.
Publicado: (2020)

A Trial of Complement Inhibition in a Patient with Cryoglobulin-Induced Glomerulonephritis
por: Hirt-Minkowski, Patricia, et al.
Publicado: (2012)

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
por: Urwyler, Pascal, et al.
Publicado: (2020)

No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus
por: Kieninger-Gräfitsch, A., et al.
Publicado: (2020)

Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients
por: Bock, Merete, et al.
Publicado: (2015)

Autoantibodies against complement component C1q in systemic lupus erythematosus
por: Trendelenburg, Marten
Publicado: (2021)

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study
por: Osthoff, Michael, et al.
Publicado: (2014)

Activation of the lectin pathway of complement in experimental human keratitis with Pseudomonas aeruginosa
por: Osthoff, Michael, et al.
Publicado: (2014)

Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial
por: Osthoff, Michael, et al.
Publicado: (2012)

Mannose-Binding Lectin Deficiency Is Associated With Smaller Infarction Size and Favorable Outcome in Ischemic Stroke Patients
por: Osthoff, Michael, et al.
Publicado: (2011)

Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial
por: Vogt, Severin, et al.
Publicado: (2021)

Low Levels of Mannan-Binding Lectin or Ficolins Are Not Associated with an Increased Risk of Cytomegalovirus Disease in HIV-Infected Patients
por: Egli, Adrian, et al.
Publicado: (2013)

Calcineurin inhibitors in systemic sclerosis – a systematic literature review
por: Hofmann, Nina N., et al.
Publicado: (2022)

Haematopoietic stem cell transplantation in systemic sclerosis
por: Walker, Ulrich A, et al.
Publicado: (2018)

Complement C1q Enhances Primary Hemostasis
por: Donat, Claudia, et al.
Publicado: (2020)

Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression
por: Urwyler, Pascal, et al.
Publicado: (2022)

Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages
por: Donat, Claudia, et al.
Publicado: (2019)

Dengue and the Lectin Pathway of the Complement System
por: Kraivong, Romchat, et al.
Publicado: (2021)

Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study
por: Bruni, Flavio, et al.
Publicado: (2022)

Serine Proteases in the Lectin Pathway of the Complement System
por: Andrade, Fabiana A., et al.
Publicado: (2017)

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
por: Jaeger, Veronika K., et al.
Publicado: (2016)

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis
por: Müller, Bettina, et al.
Publicado: (2020)

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
por: Urwyler, Pascal, et al.
Publicado: (2021)

Association between Low Levels of Mannan-Binding Lectin and Markers of Autoimmune Thyroid Disease in Pregnancy
por: Potlukova, Eliska, et al.
Publicado: (2013)

The Lectin Pathway of Complement and Rheumatic Heart Disease
por: Beltrame, Marcia Holsbach, et al.
Publicado: (2015)

Components of the Lectin Pathway of Complement in Haematologic Malignancies
por: Cedzyński, Maciej, et al.
Publicado: (2020)

Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway
por: Wallis, Russell
Publicado: (2007)

Association Study of Mannose-Binding Lectin Levels and Genetic Variants in Lectin Pathway Proteins with Susceptibility to Age-Related Macular Degeneration: A Case-Control Study
por: Osthoff, Michael, et al.
Publicado: (2015)

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial
por: Urwyler, Pascal, et al.
Publicado: (2023)

Pain chronification and the important role of non-disease-specific symptoms in patients with systemic sclerosis
por: Evers, Caroline, et al.
Publicado: (2021)

Components of the Lectin Pathway of Complement in Solid Tumour Cancers
por: Cedzyński, Maciej, et al.
Publicado: (2022)

Systemic sclerosis in sub-Saharan Africa: a systematic review
por: Erzer, Julian Nicolas, et al.
Publicado: (2020)

Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
por: Dobrota, Rucsandra, et al.
Publicado: (2016)

Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study
por: Walker, Ulrich A., et al.
Publicado: (2018)

Factors of the Lectin Pathway of Complement Activation and Their Clinical Associations in Neonates
por: Cedzynski, Maciej, et al.
Publicado: (2012)

Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques
por: Fumagalli, Stefano, et al.
Publicado: (2017)

Evasion Mechanisms Used by Pathogens to Escape the Lectin Complement Pathway
por: Rosbjerg, Anne, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f9uvp3daf02rmkqihbs8qccqs0